FITT Organises a workshop for innovation in Biotechnology and healthcare sector
While most of us are totally engulfed in the venture-capitalist propaganda, hardly do we understand how much of our shares they eat up. For a grant of ten to twenty lakhs, they usually take a five to ten percent share, and we all know how much twenty lakh actually means in the sector of innovation and development.
This is partly due to the information gap between FITT, the foundation for innovation and technology transfer, an ‘industrial interface organization’, and the students studying here. This gap is wide and not narrowing as of now. But, with this article, we aim to narrow just that, providing an opportunity to more students for funding without venture capitalists eating away too much for what they pay us.
FITT, in its workshop talked about two major funding opportunities: the Biotechnology Ignition Grant, otherwise known as BIG, a grant worth up to fifty lakhs, and Pfizer – IIT Delhi Innovation and IP Program, or PIDIIP, a popular, speedy and reliable grant, again worth up to fifty lakhs, both being awarded to innovation in healthcare and biotechnology sector.
With BIG being an indirect subsidiary of the Indian government, it focuses on developing the biotechnology sector in India, providing funding and mentorship to selected models
Pfizer, on the other hand, is an American pharmaceutical company which has teamed up with FITT, IIT Delhi. It provides Resident Incubation and IP support for technology ideas relating to medical/Health biotechnology, Medical devices/Biomaterials/ Diagnostics which may involve inter-alia.
These opportunities, discussed in the workshop, are of course just two of the multitude of funding opportunities available from FITT, which has long supported all types of innovation that might be useful to the society, or a great entrepreneurship design.
More details at: http://bsp.iitd.ac.in/pdfs/fitt.pdf